Please donate here to support this vital work.
Revealing News For a Better World

Health News Articles
Excerpts of key news articles on


Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.


Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.


We can stop the cancer epidemic
2008-09-19, New York Times
http://www.nytimes.com/2008/09/19/opinion/19iht-edservan.1.16308287.html

There is an epidemic of cancer today. One in three Americans will be diagnosed with cancer, often before the age of 65. Since 1940, we have seen in Western societies a marked and rapid increase in common types of cancer. In fact, cancer in children and adolescents has been rising by 1 to 1.5 percent a year since the 1960's. And these are cancers for which there is no screening. For most common cancers - prostate, breast, colon, lung - rates are much higher in the West than in Asian countries. Yet Asians who emigrate to the United States catch up with the rates of Americans within one or two generations. While in Asia, Asians are protected not by their genes, but by their lifestyle. We continue to invest 97 percent of our cancer research funds in better treatments and early detection. Only 3 percent is invested in tackling causes. The World Cancer Research Fund published a report in 2007 concluding that a majority of cancer cases in Western societies could be avoided with life-style measures: 40 percent from changes in diet and physical activity (more vegetables and fruits, less sugar, less red meat, regular walking or the equivalent activity 30 minutes six times per week), 30 percent from smoking cessation, and about 10 percent from reduced alcohol consumption. We now even have data about how specific foods such as broccoli and cabbages, garlic and onions, green tea or the spice turmeric directly help kill cancer cells and reduce the growth of new blood vessels they need to develop into tumors.

Note: The author of this article, Dr. David Servan-Schreiber, is a clinical professor of psychiatry at the University of Pittsburgh and a founding board member of Doctors Without Borders, USA, and author of Anticancer - A new way of life. For an excellent, inspiring 10-minute video interview with this doctor, click here.


In Rwanda, visionary doctor is moving mountains again
2008-04-13, Boston Globe
http://www.boston.com/lifestyle/articles/2008/04/13/in_rwanda_visionary_docto...

It was November 2004, and Dr. Paul Farmer had agreed to bring his world-renowned Partners in Health model to Rwanda, which was still reeling from the aftershocks of the genocide a decade earlier. Now here he was, with Rwandan health officials, to scout out a location for a hospital to serve the poorest of the poor. Farmer, who teaches at Harvard, was taken to Ruhengeri, in the country's northwest corner. But there was already a clean hospital there, with employees and even an X-ray machine. "No, no, no. You don't understand," Farmer recalls saying. "Find me the worst possible place in the country." So they took him to Rwinkwavu, a remote area two hours east of Kigali. Even Farmer - who works in the world's worst regions - was taken aback. There were no beds, no patients, no staff, no medical equipment. "It was abandoned, dirty and scary," Farmer says. There were 200,000 people in the district and not a single doctor. It was the perfect place for Farmer. In the summer of 2005, the doors opened at Rwinkwavu Hospital, which now sees 250 patients a day, some of them walking hours to get there. Farmer, [Dr. Michael Rich, who is Rwanda country director for Partners in Health], and their Rwandan counterparts have built a second hospital in an equally remote area of 200,000 - also without a single doctor - and built or renovated 19 health centers that feed patients to them. A third hospital is on the drawing board, designed by Harvard architecture students. Ultimately, they plan to expand rural medical services to the entire country. Now 20 years old, Partners in Health, with its emphasis on treating poverty as well as disease, has expanded to nine countries.

Note: Five years ago, Farmer became reluctantly famous with the publication of Tracy Kidder's best-selling book, Mountains Beyond Mountains, which told the story of the brash Harvard Medical School graduate who changed the face of healthcare in rural Haiti.


Jenny McCarthy: My son's recovery from autism
2008-04-02, CNN
http://www.cnn.com/2008/US/04/02/mccarthy.autsimtreatment/

We've met some of the most amazing moms and dads who are forging their own path to prevention and recovery. When our son, Evan, was diagnosed with autism we were lucky enough to benefit from their knowledge and experience. Evan has been healed to a great extent by many breakthroughs that, while perhaps not scientifically proven, have definitely helped Evan and many other children who are recovering from autism. We believe what helped Evan recover was starting a gluten-free, casein-free diet, vitamin supplementation, detox of metals, and anti-fungals for yeast overgrowth that plagued his intestines. Once Evan's neurological function was recovered through these medical treatments, speech therapy and applied behavior analysis helped him quickly learn the skills he could not learn while he was frozen in autism. After we implemented these therapies for one year, the state re-evaluated Evan for further services. They spent five minutes with Evan and said, "What happened? We've never seen a recovery like this." Evan is now 5 years old and what might surprise a lot of you is that we've never been contacted by a single member of the CDC, the American Academy of Pediatrics, or any other health authority to evaluate and understand how Evan recovered from autism. When Evan meets doctors and neurologists, to this day they tell us he was misdiagnosed -- that he never had autism to begin with. It's as if they are wired to believe that children can't recover from autism.

Note: This article is written by Jenny McCarthy and Jim Carrey, actors and parents actively involved in autism-related causes. McCarthy is the author of the book Louder Than Words: A Mother's Journey in Healing Autism. Don't miss a great three-minute video of McCarthy on CNN talking about her experience with vaccines and autism. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Prozac, used by 40m people, does not work say scientists
2008-02-26, The Guardian (One of the U.K.'s leading newspapers)
http://www.guardian.co.uk/society/2008/feb/26/mentalhealth.medicalresearch

Prozac, the bestselling antidepressant taken by 40 million people worldwide, does not work and nor do similar drugs in the same class, according to a major review released today. The study examined all available data on the drugs, including results from clinical trials that the manufacturers chose not to publish at the time. The trials compared the effect on patients taking the drugs with those given a placebo or sugar pill. When all the data was pulled together, it appeared that patients had improved - but those on placebo improved just as much as those on the drugs. The only exception is in the most severely depressed patients, according to the authors - Prof Irving Kirsch from the department of psychology at Hull University and colleagues in the US and Canada. But that is probably because the placebo stopped working so well, they say, rather than the drugs having worked better. "Given these results, there seems little reason to prescribe antidepressant medication to any but the most severely depressed patients, unless alternative treatments have failed," says Kirsch. "This study raises serious issues that need to be addressed surrounding drug licensing and how drug trial data is reported." The paper, published today in the journal PLoS (Public Library of Science) Medicine, is likely to have a significant impact on the prescribing of the drugs. The National Institute for Health and Clinical Excellence already recommends that counselling should be tried before doctors prescribe antidepressants.

Note: For many key reports on health issues from reliable sources, click here.


Get kids vaccinated or go to jail?
2007-11-17, USA Today/Associated Press
http://www.usatoday.com/news/health/2007-11-17-vaccines-school_N.htm

Scores of grumbling parents facing a threat of jail lined up at a courthouse Saturday to either prove that their school-age kids already had their required vaccinations or see that the youngsters submitted to the needle. The get-tough policy in the Washington suburbs of Prince George's County was one of the strongest efforts made by any U.S. school system to ensure its youngsters receive their required immunizations. Two months into the school year, school officials realized that more than 2,000 students in the county still didn't have the vaccinations they were supposed to have before attending class. So Circuit Court Judge C. Philip Nichols ordered parents in a letter to appear at the courthouse Saturday and either get their children vaccinated on the spot or risk up to 10 days in jail. They could also provide proof of vaccination or an explanation why their kids didn't have them. "It was very heavy handed," [school mom Aloma Martin] said of the county's action. "From that letter, it sounded like they were going to start putting us in jail." Any children who still lack immunizations could be expelled. Their parents could then be brought up on truancy charges, which can result in a 10-day jail sentence for a first offense and 30 days for a second. Maryland, like all states, requires children to be immunized against several childhood illnesses including polio, mumps and measles. In recent years, it also has required that students up to high school age be vaccinated against hepatitis B and chicken pox. Several organizations opposed to mass vaccinations demonstrated outside the courthouse. While the medical consensus is that vaccines are safe and effective, some people blame immunizations for a rise in autism and other medical problems. "People should have a choice" in getting their children immunized, said Charles Frohman, representing a physicians' group opposed to vaccines.

Note: For more revealing major media reports on the complex issues surrounding vaccinations, click here.


U.S. Medical Schools, Drug Makers Share Strong Ties
2007-10-16, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2007/10/16/AR20071016014...

More than half of department chairs at U.S. medical schools and teaching hospitals have financial ties with the drug industry, a new study finds. "There is not a single aspect of medicine in which the drug companies do not have substantial and deep relationships, [including] doctors-in-training, resident physicians, researchers, physicians-in-practice, the people who review drugs for the federal government and the people who review studies," said lead researcher Eric Campbell, associate professor at the Institute for Health Policy at Massachusetts General Hospital and Harvard Medical School in Boston. "Drug companies have relationships with everyone," he continued. "They're involved in every aspect of medicine. Someone has to decide which of these is OK." The study, the first to examine the extent of these institutional relationships, is published in the Oct. 17 issue of the Journal of the American Medical Association. "I think the paper is a very valuable contribution, in that it provides what's probably the first comprehensive documentation of the extent of relationships that involve department chairs, and department chairs are certainly the key agents of overseeing and maintaining the day-to-day operations of a medical school or teaching hospital," said Dr. David Korn ... at the Association of American Medical Colleges in Washington, D.C. The issue of medicine's ties to industry has been a hot one of late. One study found that third-year medical students get, on average, one gift or attend one activity sponsored by a drug maker each week. "Now it's up to the policymakers and people who run medical schools," said Campbell. "They need to come up with some rules and they need to be new rules. I believe there's very little reasonable justification for why drug companies should be involved in the education of medical students."

Note: For a powerful overview of medical corruption, click here.


Report Assails F.D.A. Oversight of Clinical Trials
2007-09-27, New York Times
http://www.nytimes.com/2007/09/28/health/policy/28fda.html?ex=1348632000&en=d...

The Food and Drug Administration does very little to ensure the safety of the millions of people who participate in clinical trials, a federal investigator has found. The inspector general of the Department of Health and Human Services, Daniel R. Levinson, said federal health officials did not know how many clinical trials were being conducted, audited fewer than 1 percent of the testing sites and, on the rare occasions when inspectors did appear, generally showed up long after the tests had been completed. The F.D.A. has 200 inspectors, some of whom audit clinical trials part time, to police an estimated 350,000 testing sites. Even when those inspectors found serious problems in human trials, top drug officials in Washington downgraded their findings 68 percent of the time, the report found. Among the remaining cases, the agency almost never followed up with inspections to determine whether the corrective actions that the agency demanded had occurred. “In many ways, rats and mice get greater protection as research subjects in the United States than do humans,” said Arthur L. Caplan, chairman of the department of medical ethics at the University of Pennsylvania. Animal research centers have to register with the federal government, keep track of subject numbers, have unannounced spot inspections and address problems speedily or risk closing, none of which is true in human research, Mr. Caplan said. Because no one collects the data systematically, there is no way to tell how safe the nation’s clinical research is or ever has been. The drug agency oversees just the safety of trials by companies seeking approval to sell drugs or devices. Using an entirely different set of rules, the Office for Human Research Protections oversees trials financed by the federal government. Privately financed noncommercial trials have no federal oversight.

Note: For further information on corruption in the health care industry, click here.


Anger at deadly Nigerian drug trials
2007-06-29, BBC News
http://news.bbc.co.uk/2/hi/africa/6768799.stm

In school, Anas Mohammadu's mates call him "horror" and make fun of him. But Anas is lucky to be alive. Other children who were used in the controversial 1996 drug trial by US pharmaceutical giant Pfizer died. Anas, then only three years old, was the first child to be given the experimental antibiotic Trovan at the Infectious Diseases Hospital, Kano, during the drug trial. Pfizer tested the then unregistered drug in Nigeria's north-western Kano State during an outbreak of meningitis which had affected thousands of children. Officials in Kano say more than 50 children died in the experiment, while many others developed mental and physical deformities. But Pfizer says only 11 of the 200 children used in the drug trial died. Following pressure from rights groups and families affected by the trial, the Nigerian government set up an expert medical panel to review the drug trial. The experiment was "an illegal trial of an unregistered drug", the Nigerian panel concluded, and a "clear case of exploitation of the ignorant". After more than a decade of silence, the Nigerian government has decided to sue Pfizer, seeking $7bn (Ł3.5bn) in damages for the families of children who allegedly died or suffered side-effects in the experiment. Kano State government has also filed separate charges against Pfizer.

Note: Pfizer settled the case out of court, as reported by BBC at this link.


Psychiatrists Top List in Drug Maker Gifts
2007-06-27, New York Times
http://www.nytimes.com/2007/06/27/health/psychology/27doctors.html?ex=1340596...

As states begin to require that drug companies disclose their payments to doctors for lectures and other services, a pattern has emerged: psychiatrists earn more money from drug makers than doctors in any other specialty. How this money may be influencing psychiatrists and other doctors has become one of the most contentious issues in health care. For instance, the more psychiatrists have earned from drug makers, the more they have prescribed a new class of powerful medicines known as atypical antipsychotics to children, for whom the drugs are especially risky and mostly unapproved. Vermont officials disclosed Tuesday that drug company payments to psychiatrists in the state more than doubled last year, to an average of $45,692 each from $20,835 in 2005. Antipsychotic medicines are among the largest expenses for the state’s Medicaid program. Over all last year, drug makers spent $2.25 million on marketing payments, fees and travel expenses to Vermont doctors, hospitals and universities, a 2.3 percent increase over the prior year, the state said. The number most likely represents a small fraction of drug makers’ total marketing expenditures to doctors since it does not include the costs of free drug samples or the salaries of sales representatives and their staff members. According to their income statements, drug makers generally spend twice as much to market drugs as they do to research them. Endocrinologists received the second largest amount, according to the Vermont analysis, earning an average of $33,730. Since the state identified the specialties of only the top 100 earners, these averages represent the money earned by only some of the state’s specialists. There were 11 psychiatrists and 5 endocrinologists in that top group of 100.

Note: For much more reliable, verifiable information on corruption in the pharmaceutical industry, click here.


Doctors’ Ties to Drug Makers Are Put on Close View
2007-03-21, New York Times
http://www.nytimes.com/2007/03/21/us/21drug.html?ex=1332129600&en=8ab21926768...

Dr. Allan Collins ... is president of the National Kidney Foundation. In 2004 ... the pharmaceutical company Amgen, which makes the most expensive drugs used in the treatment of kidney disease, underwrote more than $1.9 million worth of research and education programs led by Dr. Collins. In 2005, Amgen paid Dr. Collins at least $25,800, mostly in consulting and speaking fees. The payments to Dr. Collins and the research center ... come from Minnesota, the first of a handful of states to pass a law requiring drug makers to disclose payments to doctors. The Minnesota records are a window on the widespread financial ties between pharmaceutical companies and the doctors who prescribe and recommend their products. From [1997] through 2005, drug makers paid more than 5,500 doctors, nurses and other health care workers in the state at least $57 million. More than 100 people received more than $100,000. Research shows that doctors who have close relationships with drug makers tend to prescribe more, newer and pricier drugs — whether or not they are in the best interests of patients. Drug companies “want somebody who can manipulate in a very subtle way,” said Dr. Frederick R. Taylor. Kathleen Slattery-Moschkau, a former sales representative [said] “it all comes down to ways to manipulate the doctors.” Some of the doctors receiving the most money sit on committees that prepare guidelines instructing doctors nationwide about when to use medicines. “It is critical that the experts who write clinical guidelines be prohibited from having any conflicts of interest,” said Dr. Marcia Angell, a former editor of The New England Journal of Medicine.

Note: This article only scratches the surface of legal and illegal corruption by the powerful pharmaceutical industry. If you care about who really controls our health system, don't miss Dr. Marcia Angell's incredibly revealing essay showing the unbelievable wealth and influence of the drug companies available here.


Myths and misconceptions of the AIDS pandemic
2007-03-11, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2007/03/11/...

Many myths and misconceptions about the AIDS pandemic are spread by the Joint United Nations Program on HIV/AIDS (UNAIDS) and other mainstream AIDS agencies and activists. UNAIDS continues to perpetuate the fallacy that only aggressive HIV/AIDS prevention programs ... can prevent the eruption of heterosexual HIV epidemics. More than two decades of observation and analysis point to far different conclusions -- there are no "next waves" of HIV epidemics just around the corner. UNAIDS and most AIDS activists reject this analysis. However, all available epidemiologic data show that only the highest risk sexual behavior ... drives HIV epidemics among heterosexuals. Most AIDS activists claim, without any supporting data, that high HIV prevalence in groups of men who have sex with men or injecting drug users will inevitably "bridge" over to the rest of the population and lead to "generalized" HIV epidemics. This entrenched myth persists even though there is little, if any, HIV spread into any "general" population. Global and regional HIV rates have remained stable or have been decreasing during the past decade. HIV has remained concentrated in groups with the riskiest behavior. HIV is incapable of epidemic spread among the vast majority of heterosexuals. Most of the public, policymakers and media have no inkling that the UNAIDS working assumption is inconsistent with established facts. Scarce health resources in countries with low HIV prevalence should be targeted primarily at those who are at the highest HIV risk, instead of being misdirected to the wider public.


Drug company 'hid' suicide link
2007-01-29, BBC News
http://news.bbc.co.uk/1/hi/programmes/panorama/6291773.stm

Secret emails reveal that the UK's biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. GlaxoSmithKline (GSK) attempted to show that Seroxat worked for depressed children despite failed clinical trials. And that GSK-employed ghostwriters influenced 'independent' academics. GSK faces action in the US where bereaved families have joined together to sue the company. As a result, GSK has been forced to open its confidential internal archive. Karen Barth Menzies is a partner in one of the firms representing many of the families. She has examined thousands of the documents which are stored, box upon box, in an apartment in Malibu, California. She said: "Even when they have negative studies that show that this drug Seroxat is going to harm some kids they still spin that study as remarkably effective and safe for children." An email from a public relations executive working for GSK ... said: "Originally we had planned to do extensive media relations surrounding this study until we actually viewed the results. Essentially the study did not really show it was effective in treating adolescent depression, which is not something we want to publicise." Seroxat was banned for under 18s in 2003 after the MHRA revealed that GSK's own studies showed the drug actually trebles the risk of suicidal thoughts and behaviour in depressed children.

Note: For more reliable information on how the drug companies put profits ahead of your health, click here.


Doctor, Musician Join Fight Against Fluoride
2007-01-25, WSMV-TV (Nashville, TN NBC affiliate)
http://www.wsmv.com/health/10845643/detail.html

Fluoride has become a controversial additive to our drinking water. While no one denies it can prevent cavities with topical application, a growing number of people, cities and countries have decided that ingesting unknown quantities of fluoride is a bad idea. One of Tennessee's own top health risk scientists is asking Gov. Phil Bredesen to stop adding fluoride to the water. Dr. Kathy Thiessen makes a living assessing health risks and has worked for the Center for Disease Control and Prevention and the Environmental Protection Agency. “The deliberate exposure to uncontrolled and unmonitored intake of fluoride is unwise at best and probably harmful to a substantial number of people,” Thiessen said. Thiessen joins Tennessee lawmaker and medical doctor Joey Hensley as the most prominent Tennessee voices against fluoride. Chris White is a musician with the band Loft, but his other passion is removing fluoride from Gallatin's water supply. “All parties point to the American Dental Association recommending that mothers stop using fluoridated water for baby formula as an obvious sign that fluoride is obviously not for everyone,” he said.

Note: This article fails to mention a key recent study showing "about 28 percent of the children in the low-fluoride area scored as bright, normal or higher intelligence compared to only 8 percent in the 'high' fluoride area. In the high-fluoride city, 15 percent had scores indicating mental retardation and only 6 percent in the low-fluoride city." For a truly awesome, revealing interview with a BBC producer on the major deceptions around and dangers of fluoride in water, click here. For more on this key topic from Dr. Mercola, click here. And for the top website on the risks and dangers of flouride in water, click here.


Rise and shine: Wake up to an enhanced life
2007-01-25, CNN News
http://www.cnn.com/2007/TECH/science/01/25/ft.newdrugs

A new breed of lifestyle drugs could allow us to choose how much we sleep, boost our memories and even allow us to enjoy ourselves more, without any side effects. Will they unleash human capabilities never seen before or create a dystopian 24-hour society where we are dependent on drugs to regulate our lifestyle and behavior? One drug already available is modafinil, marketed as the vaguely Orwellian-sounding Provigil. It enables those who take it to stay awake and alert for 48 hours. It is a eugeroic that delivers a feeling of wakefulness without the physical or mental jitter. There is already a market for it for those without any medical need - it is developing a cult following among workaholics and students studying for exams. The military is also very interested in eugeroic. Their reliance on amphetamines for lengthy operations have had catastrophic consequences in the past. The "friendly-fire" incidents in Afghanistan in 2002 when U.S. pilots killed Canadian troops was blamed on the "go pills" they had taken. The U.S. Defense Advanced Research Projects Agency (DARPA) tested a compound called CX717 in its quest to find a drug that can create a "metabolically dominant war-fighter of the future" able to function for seven days without sleep. CX717 is an ampakine, a compound that increases the brains computing powers. It re-writes the rules of what it takes to create a memory and just how strong those memories can be. Will cans of soda containing eugeroics or ampakines be as common as caffeine drinks on the shelves of 24-hour stores? The potential is certainly there for a brave new world of personality medication.


Molecule offers cancer hope
2007-01-17, Toronto Star (One of Canada's leading newspapers)
http://www.thestar.com/News/article/171898

In results that "astounded" scientists, an inexpensive molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. The study was published yesterday in the journal Cancer Cell. "I think DCA can be selective for cancer because it attacks a fundamental process of cancer that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the Edmonton university's medical school and one of the study's key authors. The molecule appears to repair damaged mitochondria in cancer cells. "When a cell is getting too old or doesn't function properly, the mitochondria are going to induce the cell death," lead study author Sebastien Bonnet said yesterday. Bonnet says DCA – or dichloroacetate – appears to reverse the mitochondrial changes in a wide range of cancers. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer because all forms of cancer suppress mitochondrial function," Michelakis said. Bonnet says DCA may also provide an effective cancer treatment because its small size allows easy absorption into the body, ensuring it can reach areas that other drugs cannot, such as brain tumours. Because it's been used to combat other ailments ... DCA has been shown to have few toxic effects on the body. Its previous use means it can be immediately tested on humans. Unlike other cancer drugs, DCA did not appear to have any negative effect on normal cells. It could provide an extremely inexpensive cancer therapy because it's not patented. But ... the lack of a patent could lead to an unwillingness on the part of pharmaceutical companies to fund expensive clinical trials.

Note: Even these scientists realize that though this discovery could be a huge benefit to mankind, because the drug companies will lose profits, they almost certainly will not fund studies. Expensive AIDS drugs with promising results, on the other hand, are rushed through the studies to market. For more reliable, verifiable information on how hugely beneficial health advances are shut down to keep profits high, click here and here.


Industry 'paid top cancer expert'
2006-12-08, BBC News
http://news.bbc.co.uk/1/hi/health/6220440.stm

The scientist who first linked smoking to lung cancer was [later] paid by a chemicals firm while investigating cancer risks in the industry. Professor Sir Richard Doll held a consultancy post with US firm Monsanto for more than 20 years. The BBC has seen private letters which show that Sir Richard ... received a US$1,500-a-day consultancy fee from Monsanto in the mid-1980s. During that time he investigated the potential cancer causing properties of the powerful herbicide Agent Orange, made by the company. Sir Richard [argued] that there was no evidence that Agent Orange caused cancer. Professor Lennart Hardell, of the Oncology Department at University Hospital Orebro, Sweden, has also studied the potential hazards posed by Agent Orange. He was one of the scientists whose work was dismissed by Sir Richard. He said: "It's quite OK to have contacts with industry, but you should be fair and say 'well, I'm [working] as a consultant for Monsanto." Further documents obtained by The Guardian newspaper allegedly show that Sir Richard was also paid a Ł15,000 fee by the Chemical Manufacturers Association, and chemicals companies Dow Chemicals and ICI for a review of vinyl chloride, used in plastics, which largely cleared the chemical of any link with cancers apart from liver cancer. Sir Richard's views on the chemical were used by the manufacturers' trade association to defend it for more than a decade.


U.S. signs deal to stockpile anti-bird-flu drug
2006-07-01, San Francisco Chronicle
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/07/01/MNGDMJNKP21.DTL&h...

Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.

Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu


Experts Defining Mental Disorders Are Linked to Drug Firms
2006-04-20, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/04/19/AR20060419025...

Every psychiatric expert involved in writing the standard diagnostic criteria for disorders such as depression and schizophrenia has had financial ties to drug companies that sell medications for those illnesses, a new analysis has found. Of the 170 experts in all who contributed to the manual that defines disorders from personality problems to drug addiction, more than half had such ties, including 100 percent of the experts who served on work groups on mood disorders and psychotic disorders. "I don't think the public is aware of how egregious the financial ties are in the field of psychiatry," said Lisa Cosgrove, a clinical psychologist at the University of Massachusetts in Boston. The analysis comes at a time of growing debate over the rising use of medication as the primary or sole treatment for many psychiatric disorders, a trend driven in part by definitions of mental disorders in the psychiatric manual. Cosgrove said she began her research after discovering that five of six panel members studying whether certain premenstrual problems are a psychiatric disorder had ties to Eli Lilly & Co., which was seeking to market its drug Prozac to treat those symptoms. The process of defining such disorders is far from scientific, Cosgrove added: "You would be dismayed at how political the process can be."


The Cutter Incident: How America's First Polio Vaccine Led to a Growing Vaccine Crisis
2006-03-01, Journal of the Royal Society of Medicine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383764/

In April 1955 more than 200,000 children in five Western and mid-Western USA states received a polio vaccine in which the process of inactivating the live virus proved to be defective. Within days there were reports of paralysis and within a month the first mass vaccination programme against polio had to be abandoned. The vaccine, manufactured by the California-based family firm of Cutter Laboratories, had caused 40,000 cases of polio, leaving 200 children with varying degrees of paralysis and killing 10. Paul Offit ... sets the 'Cutter incident' in the context of the struggle of medical science against polio. He profiles leading figures, notably Jonas Salk and Albert Sabin. Reviewing failures in the manufacturing and inspection processes, he exonerates Salk from blame and concludes that `the federal government, through its vaccine regulatory agency... was in the best position to avoid the Cutter tragedy'. As Offit observes, 'ironically, the Cutter incident - by creating the perception among scientists and the public that Salk's vaccine was dangerous - led in part to the development of a polio vaccine that was more dangerous'. [A] court ruling that Cutter was liable to pay compensation to those damaged by its polio vaccine ... opened the floodgates to a wave of litigation. As a result, 'vaccines were among the first medical products almost eliminated by lawsuits'. The National Vaccine Injury Compensation Program was introduced in 1986 to protect vaccine manufacturers from litigation.

Note: Explore an eye-opening article titled "15 Things You Don’t Know About Polio" which shows how the public has been greatly deceived. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.


Remember Anthrax?
2005-11-02, Newsweek
http://msnbc.msn.com/id/9900947/site/newsweek

Just as President George W. Bush is launching an ambitious plan to guard against an avian flu pandemic, an administration program to prepare for a potential anthrax attack is running into new and unexpected hurdles. VaxGen Inc., a California biotech firm that last year was awarded an $877.5 million contract to supply a newly invented, and so far unlicensed, anthrax vaccine, acknowledged this week that it won't begin to start deliveries to the federal government until the latter part of next year -- six months later than it originally intended. For months, investigators on both sides of the aisle have expressed concerns that the administration may have invested too big a chunk of the nation's biodefenses in one obscure and relatively untested company. Last year's decision by HHS to award the contract to the little-known VaxGen is being scrutinized by at least two congressional committees. The company's product will have to pass more large-scale tests proving its safety and effectiveness on people before it is fully licensed by the Food and Drug Administration for use on humans, and company officials say they do not expect it to be fully licensed at least until 2007. A New York Times report last December noted that...the company had faced lawsuits filed by investors who claimed VaxGen misinformed them about an AIDS vaccine that the company had heavily promoted but which later failed to work.

Note: For more on how greed and corruption in the pharmaceutical industry affects your health and wallet, see our Health Information Center.


Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Kindly donate here to support this inspiring work.

Subscribe to our free email list of underreported news.

newsarticles.media is a PEERS empowerment website

"Dedicated to the greatest good of all who share our beautiful world"